NO318219B1 - Fremgangsmate ved fremstilling av spraygranuler inneholdende riboflavin - Google Patents
Fremgangsmate ved fremstilling av spraygranuler inneholdende riboflavin Download PDFInfo
- Publication number
- NO318219B1 NO318219B1 NO20002283A NO20002283A NO318219B1 NO 318219 B1 NO318219 B1 NO 318219B1 NO 20002283 A NO20002283 A NO 20002283A NO 20002283 A NO20002283 A NO 20002283A NO 318219 B1 NO318219 B1 NO 318219B1
- Authority
- NO
- Norway
- Prior art keywords
- riboflavin
- range
- drying process
- granules
- spray drying
- Prior art date
Links
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 title claims abstract description 225
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 title claims abstract description 113
- 229960002477 riboflavin Drugs 0.000 title claims abstract description 113
- 235000019192 riboflavin Nutrition 0.000 title claims abstract description 113
- 239000002151 riboflavin Substances 0.000 title claims abstract description 113
- 238000000034 method Methods 0.000 title claims abstract description 53
- 239000008187 granular material Substances 0.000 title claims abstract description 34
- 239000007921 spray Substances 0.000 title description 3
- 239000013078 crystal Substances 0.000 claims abstract description 51
- 230000004048 modification Effects 0.000 claims abstract description 37
- 238000012986 modification Methods 0.000 claims abstract description 37
- 230000008569 process Effects 0.000 claims abstract description 29
- 238000001694 spray drying Methods 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 17
- 239000007900 aqueous suspension Substances 0.000 claims abstract description 8
- 230000009969 flowable effect Effects 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 239000011651 chromium Substances 0.000 claims 1
- 238000010410 dusting Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000003825 pressing Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 239000000725 suspension Substances 0.000 description 14
- 238000001914 filtration Methods 0.000 description 11
- 239000012528 membrane Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 8
- 239000012535 impurity Substances 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/12—Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
- C07D475/14—Benz [g] pteridines, e.g. riboflavin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99108476 | 1999-04-30 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20002283D0 NO20002283D0 (no) | 2000-04-28 |
| NO20002283L NO20002283L (no) | 2000-10-31 |
| NO318219B1 true NO318219B1 (no) | 2005-02-21 |
Family
ID=8238078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002283A NO318219B1 (no) | 1999-04-30 | 2000-04-28 | Fremgangsmate ved fremstilling av spraygranuler inneholdende riboflavin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6723346B1 (fr) |
| EP (1) | EP1048668B2 (fr) |
| JP (1) | JP4965013B2 (fr) |
| KR (1) | KR100720202B1 (fr) |
| CN (1) | CN1198595C (fr) |
| AT (1) | ATE231864T1 (fr) |
| AU (1) | AU770320B2 (fr) |
| BR (1) | BR0002390A (fr) |
| CA (1) | CA2306502A1 (fr) |
| DE (1) | DE60001286T3 (fr) |
| DK (1) | DK1048668T3 (fr) |
| ES (1) | ES2189711T5 (fr) |
| ID (1) | ID25698A (fr) |
| MX (1) | MXPA00004185A (fr) |
| NO (1) | NO318219B1 (fr) |
| TW (1) | TWI253347B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219815D0 (en) * | 2002-08-24 | 2002-10-02 | Accentus Plc | Preparation of small crystals |
| DE10317051A1 (de) * | 2003-04-11 | 2004-10-21 | Basf Ag | Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform |
| ES2332787T3 (es) * | 2003-07-22 | 2010-02-12 | Dsm Ip Assets B.V. | Procedimiento para la purificacion de rivoflavina. |
| EP2107934B1 (fr) * | 2006-12-07 | 2019-11-20 | FrieslandCampina Nederland B.V. | Procédé et appareil de séchage par pulvérisation |
| CN104961740B (zh) * | 2015-06-02 | 2016-04-27 | 湖北广济药业股份有限公司 | 一种含核黄素的固体制剂及其制备方法 |
| BR112021008614A2 (pt) | 2018-11-07 | 2021-11-03 | Dsm Ip Assets Bv | Medicamentos que contêm riboflavina que exibem fluidez aprimorada |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE91686T1 (de) * | 1987-09-18 | 1993-08-15 | Hoffmann La Roche | Neue form des riboflavins. |
| DE3819745A1 (de) * | 1988-06-10 | 1989-12-14 | Basf Ag | Verfahren zur herstellung von auf mikrobiellem wege hergestelltem riboflavin in form von sprueh- oder mikrogranulaten |
| JP2634285B2 (ja) * | 1989-03-28 | 1997-07-23 | 積水化学工業株式会社 | 放射性物質取扱所の被覆材用非灰分性樹脂組成物 |
| DE3927810A1 (de) | 1989-08-23 | 1991-02-28 | Basf Ag | Riboflavingranulate |
| US5236920A (en) * | 1990-04-30 | 1993-08-17 | Basf Corporation | Granulated riboflavin product having high flowability, high riboflavin content |
| US4994458A (en) * | 1990-04-30 | 1991-02-19 | Basf Corporation | Process for rotary fluid bed granulation of riboflavin |
| DE4014262A1 (de) | 1990-05-04 | 1991-11-07 | Basf Ag | Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung |
| US5000888A (en) * | 1990-05-23 | 1991-03-19 | Basf Corporation | Process for spray drying riboflavin to produce a granulate product having low binder content |
| JP2000112883A (ja) * | 1998-09-24 | 2000-04-21 | Internatl Business Mach Corp <Ibm> | 情報処理方法、情報処理装置、情報処理プログラムを格納する記憶媒体 |
| CA2282908A1 (fr) | 1998-10-19 | 2000-04-19 | F. Hoffmann-La Roche Ag | Procede de purification et de cristallisation de la riboflavine |
| US6093715A (en) * | 1999-03-24 | 2000-07-25 | Basf Aktiengesellschaft | Process for producing riboflavin-containing granules |
-
2000
- 2000-04-17 US US09/550,971 patent/US6723346B1/en not_active Expired - Lifetime
- 2000-04-19 DK DK00108560T patent/DK1048668T3/da active
- 2000-04-19 ES ES00108560T patent/ES2189711T5/es not_active Expired - Lifetime
- 2000-04-19 EP EP00108560A patent/EP1048668B2/fr not_active Expired - Lifetime
- 2000-04-19 AT AT00108560T patent/ATE231864T1/de not_active IP Right Cessation
- 2000-04-19 DE DE60001286T patent/DE60001286T3/de not_active Expired - Lifetime
- 2000-04-20 CA CA002306502A patent/CA2306502A1/fr not_active Abandoned
- 2000-04-26 TW TW089107796A patent/TWI253347B/zh not_active IP Right Cessation
- 2000-04-26 ID IDP20000337A patent/ID25698A/id unknown
- 2000-04-27 JP JP2000126926A patent/JP4965013B2/ja not_active Expired - Fee Related
- 2000-04-28 AU AU30189/00A patent/AU770320B2/en not_active Ceased
- 2000-04-28 BR BR0002390-6A patent/BR0002390A/pt active IP Right Grant
- 2000-04-28 CN CNB001180525A patent/CN1198595C/zh not_active Expired - Fee Related
- 2000-04-28 KR KR1020000022706A patent/KR100720202B1/ko not_active IP Right Cessation
- 2000-04-28 MX MXPA00004185A patent/MXPA00004185A/es unknown
- 2000-04-28 NO NO20002283A patent/NO318219B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60001286T3 (de) | 2010-10-28 |
| JP2000327562A (ja) | 2000-11-28 |
| MXPA00004185A (es) | 2002-03-08 |
| CN1198595C (zh) | 2005-04-27 |
| KR20010029668A (ko) | 2001-04-06 |
| JP4965013B2 (ja) | 2012-07-04 |
| ATE231864T1 (de) | 2003-02-15 |
| NO20002283L (no) | 2000-10-31 |
| CA2306502A1 (fr) | 2000-10-30 |
| NO20002283D0 (no) | 2000-04-28 |
| ID25698A (id) | 2000-11-02 |
| EP1048668B2 (fr) | 2010-06-09 |
| EP1048668A3 (fr) | 2001-03-28 |
| DE60001286T2 (de) | 2003-11-06 |
| AU3018900A (en) | 2000-11-02 |
| DE60001286D1 (de) | 2003-03-06 |
| EP1048668A2 (fr) | 2000-11-02 |
| DK1048668T3 (da) | 2003-05-26 |
| BR0002390A (pt) | 2000-10-31 |
| ES2189711T3 (es) | 2003-07-16 |
| AU770320B2 (en) | 2004-02-19 |
| EP1048668B1 (fr) | 2003-01-29 |
| KR100720202B1 (ko) | 2007-05-21 |
| CN1275375A (zh) | 2000-12-06 |
| US6723346B1 (en) | 2004-04-20 |
| ES2189711T5 (es) | 2010-07-28 |
| TWI253347B (en) | 2006-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4777051A (en) | Process for the production of a composition for animal feed | |
| KR100647951B1 (ko) | 리보플라빈의 정제 및 결정화 방법 | |
| NO318219B1 (no) | Fremgangsmate ved fremstilling av spraygranuler inneholdende riboflavin | |
| EP0274728A1 (fr) | Procédé pour la purification de tryptophane | |
| US5529911A (en) | Preparation of granules containing salinomycin | |
| JP4588166B2 (ja) | ソルビン酸カリウム造粒物及びその製造法 | |
| EP0398544B1 (fr) | Purification d'hydrolysats de protéines | |
| WO2006125286A1 (fr) | Procede de production de dextrose cristalline anhydre sans pyrogene a haute purete a partir du saccharose | |
| US7329748B2 (en) | Method for the production of riboflavin of modification b/c in granular form | |
| US20240262779A1 (en) | Co-crystal of citric acid and glycine and uses thereof | |
| JP3776160B2 (ja) | Ｄ−パントテン酸カルシウムの製造法 | |
| BRPI0002390B1 (pt) | Method for producing riboflavina granules, uses of the granulates sought, and process for producing tablets | |
| AU593642B2 (en) | Process for the production of a composition for animal feed |